ACRS

Monahan Joseph

Known title: Chief Scientific OfficerCIK: 0001861790

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 16, 2026

ACRS Not Highlighted in Recent Pre‑Market Moves. In the past week, pre‑market activity focused on large financial names and a list of 20 stocks, but Aclaris Therapeutics was not mentioned. The moves in big banks and other sectors could influence overall market sentiment, which may affect smaller biotech names like ACRS. No direct company news was reported, so the impact is limited at this time.

this person other insiders at ACRS

Transaction History

ACRS▲ Buy—
ACRS▼ Sell$54K
ACRS▲ Buy—
ACRS▲ Buy—
ACRS▲ Buy—
ACRS▼ Sell$28K
ACRS▲ Buy—
ACRS▼ Sell—
ACRS▲ Buy—
ACRS▼ Sell—
ACRS▼ Sell$0
ACRS▼ Sell$4K
ACRS▲ Buy—
ACRS▲ Buy—
ACRS▼ Sell$18K
ACRS▲ Buy—
ACRS▼ Sell$4K
ACRS▲ Buy—
ACRS▼ Sell$3K
ACRS▼ Sell$30K
ACRS▼ Sell$44K
ACRS▼ Sell$62K
ACRS▼ Sell$203K
ACRS▼ Sell$183K
ACRS▲ Buy—
ACRS▲ Buy—
ACRS▲ Buy—
ACRS▲ Buy—
ACRS▼ Sell$65K
ACRS▼ Sell$79K
ACRS▼ Sell$80K
ACRS▼ Sell$488K
ACRS▼ Sell$427K
ACRS▲ Buy—
ACRS▲ Buy—
ACRS▲ Buy—
ACRS▼ Sell$5K
ACRS▲ Buy—
ACRS▼ Sell$18K
ACRS▲ Buy—

We use analytics to understand how market-wall is used. No personal data is sold.